Natural history and progression of metabolic dysfunction-associated steatotic liver disease
Hannes Hagström, Ying Shang, Hannes Hegmar et al. · The Lancet. Gastroenterology & hepatology · 2024
Cited by 299 works. doi:10.1016/s2468-1253(24)00193-6
Authors
References
- Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies
- The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
- Association of All-Cause Mortality With Overweight and Obesity Using Standard Body Mass Index Categories
- Long‐term follow‐up of patients with NAFLD and elevated liver enzymes†‡
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease
- Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
- Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
- Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease
- SAMPLING VARIABILITY AND ITS INFLUENCE ON THE DIAGNOSTIC YIELD OF PERCUTANEOUS NEEDLE BIOPSY OF THE LIVER